This inventor holds 6 USPTO granted patents, plus 4 CIPO patents and 3 EPO patents. Top assignees: Toray Industries, Inc., Tokyo Metropolitan Institute of Medical Science, Tokyo Metropolitan Organization for Medical Research. Active years: 2010-2015.
Location History:
- Fuchu, JP (2013)
- Tokyo, JP (2010 - 2015)
Company Filing History:
6 out of 3,578 
3 out of 56 
3 out of 11 Years Active: 2010-2015
Title: Michiko Miyamoto: Innovator in Hepatitis C Research
Introduction
Michiko Miyamoto is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of hepatitis C research, holding a total of 6 patents. Her work focuses on the development of modified hepatitis C virus genomic RNA and methods for producing hepatitis C virus particles.
Latest Patents
Miyamoto's latest patents include a modified human hepatitis C virus genomic RNA that can be autonomously replicated. This invention provides a genomic RNA comprising nucleotide sequences of various hepatitis C virus types, allowing for efficient replication. Another notable patent involves a method for replicating a full-length HCV genomic sequence and producing HCV virus particles using a cell culture system. This method also relates to the development of a hepatitis C vaccine and antibodies against hepatitis C virus particles.
Career Highlights
Throughout her career, Michiko Miyamoto has worked with esteemed organizations such as Toray Industries, Inc. and the Tokyo Metropolitan Organization for Medical Research. Her research has significantly advanced the understanding and treatment of hepatitis C.
Collaborations
Miyamoto has collaborated with notable colleagues, including Takaji Wakita and Takanobu Kato, contributing to her innovative research efforts.
Conclusion
Michiko Miyamoto's work in hepatitis C research exemplifies her dedication to innovation and her impact on medical science. Her patents and collaborations continue to pave the way for advancements in the treatment of hepatitis C.